Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    MRSA Superbug Protein Structure Solved

    By Global Biodefense StaffFebruary 19, 2014
    Share
    Facebook LinkedIn Reddit Email

    A research team from Vanderbilt University Medical Center is the first to decipher the 3-D structure of a protein that confers antibiotic resistance from one of the most worrisome disease agents: methicillin-resistant Staphylococcus aureus (MRSA). The Vanderbilt team’s findings may be an important step in combating the MRSA public health threat over the next 5 to 10 years.

    By deciphering the shape of a key S. aureus protein — an enzyme called FosB that inactivates an antibiotic called fosfomycin — the researchers have set the stage to devising a therapeutic method to inhibit FosB and hence improve the efficacy of the antibiotic.

    FosB from Staphylococcus aureus
    Overall ribbon diagram of FosB from Staphylococcus aureus. The unique “door” highlighted in orange is shown in the open position. Credit: M.Thompson/Vanderbilt

    “Our hope is that now that we know the 3-D shape and overall function of the FosB protein, we will be able to design inhibitors of FosB that will enable fosfomycin to function appropriately as an antibiotic,” said Matthew K. Thompson, a postdoctoral researcher on the team. “When we can successfully do that, we may very well be able to combat S. aureus infections with fosfomycin.”

    Identifying the FosB protein’s three-dimensional structure helps scientists understand that protein’s particular function. In particular, the new structural images of FosB, obtained by a technique called X-ray crystallography, provide insight into the functional role of a particular part of the protein’s shape called a binding loop. It appears to function like a door that opens and closes to allow the antibiotic to enter the active site of FosB.

    In addition to providing new insight on the function of this S. aureus protein, the research has also produced new evidence for the role zinc might play in inhibiting FosB. This could impact restoring the efficacy of fosfomycin, leading to treatment for a variety of multi-drug-resistant pathogens.

    The team presented its work this week at the 58th Annual Meeting of the Biophysical Society: Structure and Function of the Genomically-encoded Fosfomycin Resistance Enzyme, FOSB, from Staphylococcus aureus.

    Antimicrobials MRSA
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleLyme Disease: Ticks May Cause Double Trouble
    Next Article DTRA Contracts for Botulinum Neurotoxin Countermeasures Research

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Case Study: Fatal Avian Influenza Infection in Cat in Poland

    September 15, 2023

    Bird Flu Undergoing Changes That Could Increase Risk of Widespread Human Transmission

    September 14, 2023

    New Research on Causes of Brain Swelling in Cerebral Malaria

    September 13, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy